BTG Plc (BTG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH66560D
- Pages: 48
- November 2018
- Total Views:1166
- Region : Europe
- GlobalData
- Equity Research Report

Details
Summary
BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops products and acquires or in-licenses from other companies. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, Europe and Asia. BTG is headquartered in London, England, the UK.
BTG Plc (BTG)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BTG Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BTG Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BTG Plc, Medical Devices Deals, 2012 to YTD 2018 9
BTG Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BTG Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BTG International Enters into Agreement with Biologics 11
BTG Enters into Co-Development Agreement with Mirada Medical 12
Licensing Agreements 13
Carrick Therapeutics Enters into Licensing Agreement with BTG 13
Wellstat Therapeutics Enters Into Licensing Agreement With BTG For Uridine Triacetate 14
Equity Offering 16
BTG to Raise USD235 Million in Private Placement of Shares 16
BTG Completes Private Placement Of Shares For USD 160 Million 18
Asset Transactions 19
Eckert & Ziegler Acquires Brachytherapy Business From BTG 19
BTG Plc-Key Competitors 20
BTG Plc-Key Employees 21
BTG Plc-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 25
Strategy And Business Planning 25
Oct 12, 2018: BTG licences ovarian cancer candidate to Carrick Therapeutics 25
Financial Announcements 26
May 15, 2018: BTG: Final Results For year ended 31 March 2018 26
Nov 14, 2017: BTG: Interim Results 32
May 16, 2017: BTG: Final Results 38
Corporate Communications 41
Oct 04, 2018: BTG announce Directorate change 41
Jan 23, 2018: BTG Names As Anne Thorburn Non-executive Director of the Board 42
Nov 27, 2017: BTG Announced the Appointment of Non-executive Director 43
Nov 14, 2017: BTG: Directorate change-Chief Financial Officer 44
Government and Public Interest 45
Apr 04, 2018: SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program 45
Jun 07, 2017: SIO Announces First Grants in Interventional Oncology / Immuno-Oncology Research Programme 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
List Of Figure
List of Figures
BTG Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BTG Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BTG Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BTG Plc, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
BTG Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BTG Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BTG Plc, Deals By Therapy Area, 2012 to YTD 2018 8
BTG Plc, Medical Devices Deals, 2012 to YTD 2018 9
BTG Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BTG International Enters into Agreement with Biologics 11
BTG Enters into Co-Development Agreement with Mirada Medical 12
Carrick Therapeutics Enters into Licensing Agreement with BTG 13
Wellstat Therapeutics Enters Into Licensing Agreement With BTG For Uridine Triacetate 14
BTG to Raise USD235 Million in Private Placement of Shares 16
BTG Completes Private Placement Of Shares For USD 160 Million 18
Eckert & Ziegler Acquires Brachytherapy Business From BTG 19
BTG Plc, Key Competitors 20
BTG Plc, Key Employees 21
BTG Plc, Subsidiaries 22
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
BTG Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops products and acquires or in-licenses from other companies. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, Europe and Asia. BTG is headquartered in London, England, the UK.
BTG Plc (BTG)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BTG Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BTG Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BTG Plc, Medical Devices Deals, 2012 to YTD 2018 9
BTG Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BTG Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BTG International Enters into Agreement with Biologics 11
BTG Enters into Co-Development Agreement with Mirada Medical 12
Licensing Agreements 13
Carrick Therapeutics Enters into Licensing Agreement with BTG 13
Wellstat Therapeutics Enters Into Licensing Agreement With BTG For Uridine Triacetate 14
Equity Offering 16
BTG to Raise USD235 Million in Private Placement of Shares 16
BTG Completes Private Placement Of Shares For USD 160 Million 18
Asset Transactions 19
Eckert & Ziegler Acquires Brachytherapy Business From BTG 19
BTG Plc-Key Competitors 20
BTG Plc-Key Employees 21
BTG Plc-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 25
Strategy And Business Planning 25
Oct 12, 2018: BTG licences ovarian cancer candidate to Carrick Therapeutics 25
Financial Announcements 26
May 15, 2018: BTG: Final Results For year ended 31 March 2018 26
Nov 14, 2017: BTG: Interim Results 32
May 16, 2017: BTG: Final Results 38
Corporate Communications 41
Oct 04, 2018: BTG announce Directorate change 41
Jan 23, 2018: BTG Names As Anne Thorburn Non-executive Director of the Board 42
Nov 27, 2017: BTG Announced the Appointment of Non-executive Director 43
Nov 14, 2017: BTG: Directorate change-Chief Financial Officer 44
Government and Public Interest 45
Apr 04, 2018: SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program 45
Jun 07, 2017: SIO Announces First Grants in Interventional Oncology / Immuno-Oncology Research Programme 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
List Of Figure
List of Figures
BTG Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BTG Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BTG Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BTG Plc, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
BTG Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BTG Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BTG Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BTG Plc, Deals By Therapy Area, 2012 to YTD 2018 8
BTG Plc, Medical Devices Deals, 2012 to YTD 2018 9
BTG Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BTG International Enters into Agreement with Biologics 11
BTG Enters into Co-Development Agreement with Mirada Medical 12
Carrick Therapeutics Enters into Licensing Agreement with BTG 13
Wellstat Therapeutics Enters Into Licensing Agreement With BTG For Uridine Triacetate 14
BTG to Raise USD235 Million in Private Placement of Shares 16
BTG Completes Private Placement Of Shares For USD 160 Million 18
Eckert & Ziegler Acquires Brachytherapy Business From BTG 19
BTG Plc, Key Competitors 20
BTG Plc, Key Employees 21
BTG Plc, Subsidiaries 22
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
BTG Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.